120 related articles for article (PubMed ID: 7885342)
1. Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy.
Zhong XH; Haycock JW; Shannak K; Robitaille Y; Fratkin J; Koeppen AH; Hornykiewicz O; Kish SJ
Mov Disord; 1995 Jan; 10(1):10-7. PubMed ID: 7885342
[TBL] [Abstract][Full Text] [Related]
2. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
3. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
[TBL] [Abstract][Full Text] [Related]
5. [Olivopontocerebellar atrophy and Parkinson's disease: diagnostic problems].
Rodríguez M; Artieda J; Zubieta JL; Obeso JA
Neurologia; 1994 Jan; 9(1):4-11. PubMed ID: 8161468
[TBL] [Abstract][Full Text] [Related]
6. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
Kish SJ; Tong J; Hornykiewicz O; Rajput A; Chang LJ; Guttman M; Furukawa Y
Brain; 2008 Jan; 131(Pt 1):120-31. PubMed ID: 17956909
[TBL] [Abstract][Full Text] [Related]
7. Temporal and spatial development of serotonin and dopamine neurons in the Drosophila CNS.
Lundell MJ; Hirsh J
Dev Biol; 1994 Oct; 165(2):385-96. PubMed ID: 7958407
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease.
Ryoo HL; Pierrotti D; Joyce JN
Mov Disord; 1998 Sep; 13(5):788-97. PubMed ID: 9756147
[TBL] [Abstract][Full Text] [Related]
9. [3H]DOPA formed from [3H]tyrosine in living rat brain is not committed to dopamine synthesis.
Cumming P; Ase A; Kuwabara H; Gjedde A
J Cereb Blood Flow Metab; 1998 May; 18(5):491-9. PubMed ID: 9591841
[TBL] [Abstract][Full Text] [Related]
10. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
11. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
12. Catecholamine-related enzymes and the biopterin cofactor in Parkinson's disease and related extrapyramidal diseases.
Nagatsu T; Yamaguchi T; Rahman MK; Trocewicz J; Oka K; Hirata Y; Nagatsu I; Narabayashi H; Kondo T; Iizuka R
Adv Neurol; 1984; 40():467-73. PubMed ID: 6141712
[TBL] [Abstract][Full Text] [Related]
13. Reduced Gs protein function and G alpha s levels in leukocytes of patients with Parkinson's disease.
Avissar S; Barki-Harrington L; Herishanu Y; Schreiber G
Mov Disord; 1997 Mar; 12(2):167-74. PubMed ID: 9087974
[TBL] [Abstract][Full Text] [Related]
14. Aging of the rat mesostriatal system: differences between the nigrostriatal and the mesolimbic compartments.
Cruz-Muros I; Afonso-Oramas D; Abreu P; Barroso-Chinea P; Rodríguez M; González MC; Hernández TG
Exp Neurol; 2007 Mar; 204(1):147-61. PubMed ID: 17112516
[TBL] [Abstract][Full Text] [Related]
15. CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathies.
Riederer P; Rausch WD; Birkmayer W; Jellinger K; Seemann D
J Neural Transm Suppl; 1978; (14):121-31. PubMed ID: 39974
[TBL] [Abstract][Full Text] [Related]
16. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA
J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683
[TBL] [Abstract][Full Text] [Related]
17. [The changes of striatal dopamine levels in the brain in rat models for Parkinson's disease after gene therapy].
Tong H; Zhang J; Xu Q
Zhonghua Yi Xue Za Zhi; 1996 Jul; 76(7):490-2. PubMed ID: 9275495
[TBL] [Abstract][Full Text] [Related]
18. [Ladasten induces the expression of genes regulating dopamine biosynthesis in various structures of rat brain].
Vakhitova IuV; Iamidanov RS; Seredinin SB
Eksp Klin Farmakol; 2004; 67(4):7-11. PubMed ID: 15500036
[TBL] [Abstract][Full Text] [Related]
19. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
Chu Y; Kordower JH
Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
